Innate Pharma S.A. - stock earnings

IPHA Quarterly earnings

DateEarningsRevenue
2023Q2 1.9 million USD 38.4 million USD
2023Q1 -70.2 million USD 9.1 million USD
2022Q4 921854 USD 21.6 million USD
2022Q3 -31.6 million USD 5.9 million USD
2022Q2 3.2 million USD 22.8 million USD
2022Q1 3.2 million USD 22.8 million USD
2021Q2 -11.9 million EUR 7.8 million EUR
2021Q1 -11.9 million EUR 7.8 million EUR
2020Q4 -26.8 million EUR 16.9 million EUR
2020Q3 -26.8 million EUR 16.9 million EUR
2020Q2 -5.8 million USD 20.6 million USD
2020Q1 ? USD 20.3 million USD
2019Q4 -75.2 million USD 58.9 million USD
2019Q3 -52.3 million USD 41.0 million USD
2019Q2 32.1 million USD 143.6 million USD
2019Q1 29.4 million USD 131.3 million USD
2018Q4 12.6 million USD 46.1 million USD
2018Q3 13.0 million USD 47.3 million USD

IPHA Yearly earnings

DateEarningsRevenue
2022 -106.4 million USD 53.3 million USD
2021 -67.3 million USD 13.8 million USD
2020 -86.2 million USD 69.2 million USD
2019 -23.5 million USD 77.3 million USD
2018 3.5 million USD 91.4 million USD
2017 -57.8 million USD 39.0 million USD
2016 13.3 million USD 59.1 million USD
2015 -7.3 million USD 19.6 million USD
2014 -23.9 million USD 1.1 million USD
2013 -4.0 million USD 17.2 million USD
2012 -4.2 million USD 13.7 million USD
2011 -9.0 million USD 15.2 million USD
2010 -18.2 million USD 5.7 million USD
2009 -21.0 million USD 11.1 million USD
2008 -13.7 million USD 18.0 million USD
2007 -13.0 million USD 20.9 million USD
2006 -8.0 million USD 8.2 million USD
2005 -7.3 million USD 1.5 million USD

IPHA

Price: $2.49

52 week price:
1.81
3.57

Earnings Per Share: -0.10 USD

P/E Ratio: -3.06

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 6529

Market Capitalization: 205.8 million

Links: